Stocklytics Platform
Asset logo for symbol IART
Integra LifeSciences Holdings
IART58
$31.43arrow_drop_down0.31%-$0.10
Asset logo for symbol IART
IART58

$31.43

arrow_drop_down0.31%

Performance History

Chart placeholder
Key Stats
Open$31.77
Prev. Close$31.53
EPS0.51
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range30.82
32.19
52 Week Range22.36
46.75
Ratios
EPS0.51

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$382.01B
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About Integra LifeSciences Holdings (IART)

Integra LifeSciences Holdings Corp (IART) is a global leader in medical technology, dedicated to offering innovative solutions for patients and healthcare professionals. With a rich history dating back over 30 years, Integra has established itself as a trusted provider of high-quality medical devices and instruments. The company's commitment to improving outcomes for patients is reflected in its diverse portfolio of products, which span the fields of neurosurgery, orthopedics, reconstructive and general surgery, and more. Whether it's developing cutting-edge implants or advanced surgical instruments, Integra is constantly pushing the boundaries of medical innovation.
One of the key strengths of Integra LifeSciences Holdings Corp is its unwavering focus on research and development. The company invests heavily in new technologies and therapies, ensuring that it remains at the forefront of medical advancements. This commitment to innovation has been recognized by peers and experts in the industry, earning Integra numerous accolades and awards. By combining its expertise in medical science with a deep understanding of patient needs, Integra is able to deliver groundbreaking solutions that improve patient outcomes and enable healthcare professionals to provide the best possible care.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Jan De Witte
Headquarters
Princeton
Employees
3722
Exchange
NASDAQ
add Integra LifeSciences Holdings to watchlist

Keep an eye on Integra LifeSciences Holdings

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the 52-week high and low for Integra LifeSciences Holdings (IART)?
For Integra LifeSciences Holdings (IART), the 52-week high is $46.75, which is 48.74% from the current price. The 52-week low is $22.36, the current price is 40.56% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
What is Integra LifeSciences Holdings's (IART) price per share?
The current price per share for Integra LifeSciences Holdings (IART) is $31.43. The stock has seen a price change of -$0.1 recently, indicating a -0.32% change. This reflects the stock's recent market performance and investor sentiment.
help
Is Integra LifeSciences Holdings (IART) a growth stock?
Integra LifeSciences Holdings (IART) has shown an average price growth of 0.41% over the past three years. It has received a score of 23 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Integra LifeSciences Holdings as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Integra LifeSciences Holdings (IART) stock price performance year to date (YTD)?
As of the latest data, Integra LifeSciences Holdings (IART) has a year-to-date price change of -27.33%. Over the past month, the stock has experienced a price change of 9.06%. Over the last three months, the change has been 10.63%. Over the past six months, the figure is -24.79%. Looking at a longer horizon, the five-year price change stands at -49.42%.
help
Is Integra LifeSciences Holdings (IART) a profitable company?
Integra LifeSciences Holdings (IART) has a net income of $67.74M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 57.63% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 10.98% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.54B, although specific revenue growth data is currently not available. The gross profit is $888.39M. Operating income is noted at $174.08M. Furthermore, the EBITDA is $221.9M.
help
What is the market capitalization of Integra LifeSciences Holdings (IART)?
Integra LifeSciences Holdings (IART) has a market capitalization of $2.53B. The average daily trading volume is 993.45K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level